Brown Advisory’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Brown Advisory's RMD Position: Q2 2026 in Review
Brown Advisory reduced its ResMed (RMD) stake by 16% in Q2 2026, selling an estimated $56.2K and leaving 1,396 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #1309.
Brown Advisory first reported a position in RMD in Q2 2013 and has held it in 22 quarters since. The position peaked at $657K in Q2 2013. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Brown Advisory held 1,396 shares of ResMed worth $272K as of Q2 2026.
- Brown Advisory sold 271 ResMed shares in Q2 2026, an estimated $56.2K.
- ResMed made up ﹤0.01% of Brown Advisory's portfolio in Q2 2026, its #1309 holding.
- Brown Advisory first reported a position in ResMed in Q2 2013 and has held it in 22 quarters since.
- Brown Advisory's ResMed position peaked at $657K in Q2 2013.
- 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Brown Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.